KINGS COLLEGE LONDON
Sainsbury's
Kelly Rail
Robert Walters UK
Howett Thorpe Recruitment Consultants Ltd
Howett Thorpe Recruitment Consultants Ltd
Connect with headhunters to apply for similar jobsCareer Choices Dewis Gyrfa Ltd
Ganymede Solutions Ltd
Disney Cruise Line - The Walt Disney Company
UKRI
DVSA.GOV
Cathy Moran Recruitment
BDO UK LLP
Ark
Orka Financial Ltd
Orka Financial Ltd
Michael Page
Casanovas Recruitment Solutions
JAC Recruitment
Dimensions
JAC Recruitment
A leading research university in the UK seeks a knowledgeable Medicinal Chemistry researcher to investigate inflammation-related respiratory disorders. The role requires a Master's degree and practical experience in organic chemistry and analytical techniques. Emphasis will be on synthesizing compounds and evaluating their therapeutic effects. This part-time position is fixed until September 2026 and offers a salary of £39,735 per annum plus allowances.
Organisation/Company KINGS COLLEGE LONDON Research Field Chemistry Researcher Profile Recognised Researcher (R2) First Stage Researcher (R1) Country United Kingdom Application Deadline 4 Jan 2026 - 00:00 (UTC) Type of Contract Other Job Status Part-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
About Us
The Institute of Pharmaceutical Science (IPS) at KCL supports world class fundamental and applied research across the full spectrum of pharmaceutical science, from drug discovery through biophysical and biological characterization, pharmacology, formulation, drug delivery and use of medicines, with a strong culture of multi-disciplinary collaboration and links to clinical colleagues evidenced by awards of major grants from organisations such as MRC, BBSRC and NC3Rs. The medicinal chemistry laboratory of IPS has been recently refurbished and modernized with new equipment and facilities, and the selected candidate will be based at the medicinal chemistry laboratory at Franklin Wilkins Building.
About The Role
Inflammation drives the pathogenesis of many respiratory disorders. Established anti-inflammatory medications (e.g. glucocorticosteriods or PDE4 inhibitors) have questionable efficacy in the majority of COPD patients. Patients often suffer side effects (eg increased pneumonia risk in patients administered glucocorticosteroids; dose limiting gastrointestinal side effects with PDE4 inhibitors). Furthermore, current drugs are delivered via the inhaled route, and cannot address the issue of systemic inflammation in COPD patients that increases the likelihood of disease exacerbations, or inflammation-driven co-morbidities (e.g. cardiovascular disease) that are also life threatening.
Research into the inflammasome; and inflammatory resolving pathways are novel competing strategies, however these retain a risk of immunosuppression. Our approach is advantageous because: 1, systemic platelet activation during inflammation is a critical process that does not carry operational redundancy; 2, targeting biased P2Y1 signalling associated with inflammation eliminates side effects associated with haemostasis eg unwanted bleeding; 3, rapid anti-inflammatory effects are induced by targeting platelet activation; 4, regular platelet turnover means drug effects can be ‘washed out’ if needs be; 5, we have proven local (lung) efficacy via systemic administration of our tool compounds.
The project will provide data to allow comparisons between chemical scaffolds (involve synthesis of novel structures chosen from understanding of initial series of compounds and their performance from MRC grant MR/T015845/1) in terms of measurements of efficacy using a validated in vivo model of respiratory disease (COPD), therapeutic dosing strategy to determine duration of action, (in house); pharmacokinetic (PK) data, and early safety profiles (maximum tolerated dose MTD) outsourced to Eurofins.
This is a 0.5 FTE post, you will be offered an a fixed term contract until 30/09/2026.
About You
To be successful in this role, we are looking for candidates to have the following skills and experience:
Downloading a copy of our Job Description
Full details of the role and the skills, knowledge and experience required can be found in the Job Description document, provided at the bottom of the page. This document will provide information of what criteria will be assessed at each stage of the recruitment process.
Further Information
We pride ourselves on being inclusive and welcoming. We embrace diversity and want everyone to feel that they belong and are connected to others in our community.
We are committed to working with our staff and unions on these and other issues, to continue to support our people and to develop a diverse and inclusive culture at King's.
As part of this commitment to equality, diversity and inclusion and through this appointment process, it is our aim to develop candidate pools that include applicants from all backgrounds and communities.
We ask all candidates to submit a copy of their CV, and a supporting statement, detailing how they meet the essential criteria listed in the advert. If we receive a strong field of candidates, we may use the desirable criteria to choose our final shortlist, so please include your evidence against these where possible.
To find out how our managers will review your application, please take a look at our ‘How we Recruit ’ pages.
Interviews are due to be held in January/February.
Grade and Salary:£39,735 per annum inclusive of London Weighting Allowance
Job ID:134225
Close Date:04-Jan-2026
Contact Person:Professor Miraz Rahman
Contact Details:k.miraz.rahman@kcl.ac.uk
* The salary benchmark is based on the target salaries of market leaders in their relevant sectors. It is intended to serve as a guide to help Premium Members assess open positions and to help in salary negotiations. The salary benchmark is not provided directly by the company, which could be significantly higher or lower.